Skip to main content

Table 2 Results of bone turnover markers

From: Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial

  

Arm A

   

Arm B

   

Difference between arms

 
  

baseline, n=23

3 months, n=23

baseline, n=24

3 months, n=24

LS means

 

Parameter

Reference value

mean

SD

mean

SD

mean

SD

mean

SD

Difference (95 % CI)

p-value*

PYD

160–280 μg/g Cr

375.63

206.20

299.89

173.88

402.00

199.01

405.50

187.32

−90.92 (−175.19; −6.65)

0.035

DPD

26–65 μg/g Cr

67.30

39.64

51.20

35.81

86.10

78.85

72.88

37.11

−18.20 (−38.84; 2.45)

0.082

CTX-I

<0.5484 ng/ml

0.29

0.27

0.20

0.23

0.39

0.37

0.42

0.45

−0.10 (−0.20; −0.003))

0.043

BAP

6–15 μg/l

56.89

92.31

31.46

63.31

44.17

47.32

36.52

37.58

−12.10 (−31.51; 7.31)

0.215

NTX

5.4–24.2 nmol/l

19.09

7.21

17.42

7.98

21.42

9.36

20.38

9.81

−0.87 (−3.84; 2.10)

0.556

PINP

15–59 μg/l

67.54

40.69

49.50

41.43

87.96

51.98

66.77

39.18

−6.94 (−26.81; 12.93)

0.485

  1. *Results of ANCOVA
  2. This table shows the results of bone turnover markers of both groups at baseline and 3 months after RT. Differences are presented within and between groups
  3. Abbreviation: LS means least square means
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us